CDH1 and cancer: Thus, while multigene panel sequencing allows for rapid analysis of multiple cancer susceptibility genes, is cost-effective, and leads to incremental genetic findings, it also causes dilemmas for both patients and providers in case of incidental finding of CDH1 mutation [12,13].